The Patent Finder

Trion Pharma GmbH

Also on record
Records under this name other than patents Trion Pharma GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to Trion Pharma GmbH

PatentTitleStatus Expires Confidence
US 8,709,421Combination of the application of antibodies for immunostimulation together with glucocorticoids
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,017,676Destruction of tumor cells by trifunctional bispecific antibodies with low to medium expression levels of tumor-associated target antigens
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,605,242Removal of tumor cells from intraoperative autologous blood salvage
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,663,638Intraoperative trifunctional antibody application for prophylaxis of intraperitoneal tumor cell dissemination
Formerly held
Lapsed on the fee record
Ended Mar 4, 2026 · From the USPTO record
Lapsed on the fee recordEnded Mar 4, 2026From the USPTO record
US 8,066,989Method of treating tumor growth and metastasis by using trifunctional antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy
Formerly held
Term ended
Term ended Nov 26, 2025 · From the USPTO record
Term endedTerm ended Nov 26, 2025From the USPTO record
US 8,277,806Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites
Formerly held
Lapsed on the fee record
Ended Oct 2, 2020 · From the USPTO record
Lapsed on the fee recordEnded Oct 2, 2020From the USPTO record
US 6,994,853Time-staggered utilization of tumor cells in combination with intact antibodies for immunization
Lapsed on the fee record
Ended Feb 7, 2014 · From the USPTO record
Lapsed on the fee recordEnded Feb 7, 2014From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited